Senl_B19 CAR-T Cells

· Hebei Senlang Biotechnology Inc., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Senl_B19 CAR-T Cells, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL [Phase 2]